DRRX: DURECT Corp. Company Aggregate Debts

Symbol and logo of brand durect.com (DRRX)

DURECT Corporation is facing a liquidity shortage due to high R&D expenditures, although partnerships with medical centers for larsucofibrate testing are accelerating clinical phases. The debt load metric on the GURU.Markets chart demonstrates financial pressure, where 0.00 determines the current value of the indicator. Meanwhile, management is focusing on creating unique epigenetic agents for the regeneration of damaged organs.

DRRX: DURECT Corp Company Debts 07/04/2022 - 09/27/2025

DURECT Corporation (DRRX) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart durect.com|DRRX - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization DURECT Corp.|DRRX - Total Company Value
- balance sheet equity data:
Accounting Value of a Share DURECT|DRRX - Company Book Value|Market Cap to Net Assets Ratio durect.com|DRRX - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital DURECT Corporation|DRRX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital durect.com|DRRX - Company Debts|Debt to Book Capitalization Ratio DURECT Corp.|DRRX - Company Long-Term Debts|Short-Term Debt Volume DURECT|Quick Liquidity durect.com
Fundamental company analysis:DURECT Corp DRRX
Signature product of DURECT

Amidst a cash deficit and high R&D expenditures for liver treatment methods, DURECT Corporation (DRRX) is forced to rely on external financing. An analysis of the total borrowed funds allows for an assessment of the issuer's ability to service loans during its expansion phase, while excessive growth in debt load in the absence of revenue increases the risk of default and could trigger a decline in market quotes.

Competing companies

ARWR (Arrowhead Corp) - Aggregate Debt Obligations|Company Aggregate Debts MIRM (Mirum Pharmaceuticals)|Company Aggregate Debts Dynavax Pharma DVAX|ABUS - Company Debts|Aggregate Debt Obligations IVA (Inventiva SA)|Gyre Corp (GYRE) - Company Debts|Company Total Debt Assembly Corp|GALT (Galectin Therapeutics, Inc.) - Company Aggregate Debts|Company Aggregate Debts Genfit Corp|Company Total Debt ALGS (Aligos Therapeutics)|BIVI (biovieinc.com) - Aggregate Debt Obligations|Company Debts Galmed Pharmaceuticals Ltd. GLMD|ENDRA Corp - Company Debts|Hepion Pharma - Company Aggregate Debts